awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27853298-571AEB7E-F43F-464A-94FA-F5DEF741895B
Q27853298-571AEB7E-F43F-464A-94FA-F5DEF741895B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853298-571AEB7E-F43F-464A-94FA-F5DEF741895B
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.
P2860
Q27853298-571AEB7E-F43F-464A-94FA-F5DEF741895B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853298-571AEB7E-F43F-464A-94FA-F5DEF741895B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f4b3352f04ef6adb3a9a1364e3c05bdb7bf3667
P2860
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.